Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Institution	Shares	Value	Change
Dekabank Deutsche Girozentrale	1,475,379	$111M	UNCHANGED
Louisiana State Employees Retirement System	11,300	$854K	UNCHANGED
Ifp Advisors	54	$4K	DECREASED
Huntington National Bank	1		DECREASED

Hologic Inc (HOLX) Ownership & Trading Activity

Top Institutional Holders